FDA Inspection 1180704 — Innovative Blood Resources A Division Of New York Blood Center Inc.
The FDA completed an inspection of Innovative Blood Resources A Division Of New York Blood Center Inc. on Sep 12, 2022 in Hibbing, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 12, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hibbing, MN (United States)